85 completed. 85 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 85 | Completed 85 |
Follow Gabapentin: new trials by email Literature Review of Gabapentin trials Research Report on Gabapentin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Abuse Potential of Oral Gabapentin in Healthy, Non-Drug-Dependent Individuals With Recreational Sedative Drug Use Experience Alprazolam (Xanax), Placebo, Gabapentin (Neurontin® (Registered Trademark)) - Healthy Non-dependent, Recreational Sedative Users | Phase 4 | Completed | Viatris Inc. | 44 | 2026-06-18 | 2026-09-08 |
| Pain Reduction Caused by the Combined Treatment of Physiotherapy, Oral Gabapentin and Oral Ibuprofen Arginine. Median nerve neural mobilization, Gabapentin 300mg, Ibuprofen Arginine - Carpal Tunnel Syndrome | Phase 4 | Completed | Universidad Europea de Madrid | 129 | 2025-02-19 | 2025-12-11 |
| Gabapentin and Neural Mobilization Pain Reduction Effect Compared to Only Gabapentine Median nerve neural mobilization and oral gabapentin, Gabapentin 300mg - Carpal Tunnel Syndrome | Phase 4 | Completed | Universidad Europea de Madrid | 72 | 2025-02-19 | 2025-12-11 |
| Effect of Gabapentin on Kidney Function Following Laparoscopic Sleeve Gastrectomy (LSG) Laparoscopic Sleeve Gastrectomy, gabapentin 1200 mg - Acute Kidney Injury, Obesity | Phase 4 | Completed | Tanta University | 90 | 2024-12-01 | 2026-08-18 |
| Fexofenadine Versus Gabapentin for Uremic Pruritus in Patients on Regular Hemodialysis Fexofenadine, Gabapentin - Uremic Pruritus, Chronic Kidney Disease-associated Pruritus | Phase 4 | Completed | Tanta University | 60 | 2024-07-01 | 2025-04-27 |
| Gabapentin Versus Trospium Chloride for Prevention of a Catheter-related Bladder Discomfort Inside the ICU Gabapentin (Gaptin ®) 400mg oral capsule once, Trospium chloride slow release (Trospikan ® SR) 60mg oral capsule - Catheter-related Bladder Discomfort (CRBD) | Phase 4 | Completed | Ain Shams University | 120 | 2024-04-10 | 2025-07-28 |
| Preoperative Gabapentin vs Placebo for Vaginal Prolapse Surgery Gabapentin, Gabapentin Placebo - Pelvic Organ Prolapse, Perioperative/Postoperative Complications | Phase 4 | Completed | Joseph Kowalski | 110 | 2023-01-01 | 2025-08-12 |
| Dexmedetomidine Versus Gabapentin Premedication on the Emergence Agitation After Rhinoplasty Dexmedetomidine, Gabapentin - Anesthesia | Phase 4 | Completed | Ain Shams University | 153 | 2022-11-01 | 2023-08-30 |
| Comparative Clinical Study Evaluating the Possible Efficacy of Duloxetine, Gabapentin and Lacosamide on Oxaliplatin-Induced Peripheral Neuropathy in Cancer Patients Duloxetine, Gabapentin, Lacosamide - Oncology | Phase 4 | Completed | Tanta University | 93 | 2022-09-01 | 2024-11-22 |
| Gabapentin Versus Loratadine in Uremic Pruritus Loratadine, Gabapentin - Pruritus, Uremia | Phase 4 | Completed | King Edward Medical University | 64 | 2022-05-01 | 2023-03-16 |
| Management of Pain Associated With Failed Back Surgery Syndrome Pregabalin 75mg, Gabapentin 300mg - Failed Back Surgery Syndrome | Phase 4 | Completed | Al-Kindy College of Medicine | 60 | 2022-04-25 | 2023-05-01 |
| Nonopioid Pain Control Regimen After Arthroscopic Hip Procedures Oxycodone, Ibuprofen, Gabapentin - Hip Arthroscopy | Phase 4 | Completed | Mayo Clinic | 86 | 2022-04-07 | 2026-06-03 |
| Feasibility of Early Gabapentin as an Intervention for Neurorecovery Gabapentin, Placebo - Spinal Cord Injuries | Phase 4 | Completed | MetroHealth Medical Center | 26 | 2022-03-14 | 2026-10-01 |
| Biomarker-Driven Pharmacological Treatment of Adolescents With Autism Spectrum Disorder With Gabapentin Gabapentin - Autism Spectrum Disorder | Phase 4 | Completed | David Cochran | 16 | 2022-02-04 | 2026-02-20 |
| Short-term Effectiveness of Gabapentin Versus Placebo in Acute Lumbosacral Radiculalgia by Herniation Disc (GRADE) Gabapentin 300mg, PLACEBO - Radiculopathy of Lumbosacral Spine Due to Disc Disorder | Phase 4 | Completed | Lille Catholic University | 144 | 2022-02-02 | 2026-04-21 |
| Abuse Potential of HORIZANT With and Without Oxycodone in Healthy, Nondependent Recreational Opioid Users Placebo, Oxycodone 20 mg, GE-IR 200 mg - Abuse Potential | Phase 4 | Completed | Arbor Pharmaceuticals, Inc. | 110 | 2022-01-31 | 2024-08-12 |
| An Abuse Potential Study of Orally Administered HORIZANT in Healthy, Non-dependent, Recreational Drug Users Placebo, Alprazolam 2 mg, Gabapentin Enacarbil Immediate Release (GE-IR) 200 mg - Abuse Potential | Phase 4 | Completed | Arbor Pharmaceuticals, Inc. | 86 | 2021-09-28 | 2024-08-12 |
| Low vs. Standard Daily Doses of Antiepileptic Drugs in Newly Diagnosed, Previously Untreated Epilepsy(STANDLOW) Low dose carbamazepine, Standard dose carbamazepine, Low dose levetiracetam - Epilepsies, Partial | Phase 4 | Completed | Mario Negri Institute for Pharmacological Research | 58 | 2021-05-10 | 2025-07-08 |
| Study Evaluating the Abuse Potential of NEURONTIN® in Healthy Non-drug Dependent, Recreational Opioid Users gabapentin 600 mg, gabapentin 1200 mg, gabapentin 600 mg and oxycodone HCl 20 mg - Abuse Potential | Phase 4 | Completed | Viatris Specialty LLC | 54 | 2021-04-30 | 2023-08-14 |
| Pregabalin vs. Gabapentin on Reducing Opioid Usage Pregabalin 50mg, Gabapentin 300mg, Neither Pregabalin nor Gabapentin - Analgesics, Gabapentin | Phase 4 | Completed | CAMC Health System | 109 | 2021-04-12 | 2026-01-06 |
Showing 20 of 85. Sign in to see all of them.
Pain (14) · Pain, Postoperative (14) · Agnosia (8) · Diabetic Neuropathies (6) · Neuralgia (6) · Carpal Tunnel Syndrome (5) · Epilepsies, Partial (3) · Epilepsy (3) · Postoperative Complications (3) · Anxiety Disorders (2) · Failed Back Surgery Syndrome (2) · Head and Neck Neoplasms (2) · Neuralgia, Postherpetic (2) · Osteoarthritis, Knee (2) · Pelvic Organ Prolapse (2)
Mayo Clinic (4) · Pfizer's Upjohn has merged with Mylan to form Viatris Inc. (4) · Tanta University (3) · Universidad Europea de Madrid (3) · Ain Shams University (2) · Arbor Pharmaceuticals, Inc. (2) · MetroHealth Medical Center (2) · University of California, Davis (2) · University of Rochester (2) · Viatris Specialty LLC (2) · Al-Kindy College of Medicine (1) · Alexandria University (1) · Brigham and Women's Hospital (1) · CAMC Health System (1) · Centre of Chinese Medicine, Georgia (1)
United States (40) · Egypt (6) · Venezuela (4) · Brazil (3) · Denmark (3) · Canada (2) · France (2) · Germany (2) · Pakistan (2) · Poland (2) · Argentina (1) · Costa Rica (1) · El Salvador (1) · Guatemala (1) · Iraq (1)
Francisco Unda, PhD (4) · Ahmed M Hussein, PhD (1) · Ahmed M Mohamed, MD (1) · Barbara Jachniewicz, MSN, CRNFA, (1) · C Kim (1) · Christopher J Stock, PharmD (1) · Colin McCartney, MD (1) · David Cochran, MD (1) · Dik WH NG, PhD (1) · Dr. Kimberly Anderson, PhD (1) · Enrique Graue-Hernandez, Md, MSc (1)
PMID 10598635, PMID 12670812, PMID 15275765, PMID 16415311, PMID 16679671, PMID 16816054, PMID 17513656, PMID 18716003, PMID 20112079, PMID 20418301, PMID 21719618, PMID 23780805, PMID 24650125, PMID 24837444, PMID 26705527, PMID 27521437, PMID 29671676, PMID 29710075, PMID 30123399, PMID 30863474, PMID 31169568, PMID 32389735, PMID 32534843, PMID 32849209, PMID 33486130, PMID 34783725, PMID 35084369, PMID 36243129, PMID 36419530, PMID 36554581, PMID 37043404, PMID 37192425, PMID 37469099, PMID 39891093, PMID 41137125, PMID 4835444
2014 (1), KL2TR000370 (1), R03HD042609 (1), UL1TR000135 (1), UL1TR000371 (1)